ARID1A and non-small cell lung carcinoma: Although the biological convergence between these two pathways is not necessarily evident a priori, a recent functional genetic screen in a NSCLC cell line identified loss of function ARID1A and other SWI/SNF components as important mechanisms of resistance to EGFR inhibition in vitro54.